1. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use;Bender;Pharmacol. Rev.,2006
2. Phosphodiesterase inhibitors;Boswell-Smith;Br. J. Pharmacol.,2006
3. Hydrolysis of cyclic guanosine and adenosine 3′,5′-monophosphates by rat and bovine tissues;Beavo;J. Biol. Chem.,1970
4. U.S. Food and Drug Administration 1998
5. PDE4 inhibitors as potential therapeutic agents in the treatment of COPD-focus on roflumilast;Boswell-Smith;Int. J. Chronic Obstruct. Pulm. Dis.,2007